Purpose: To analyze the effects of aortic anatomy and endovascular aneurysm repair (EVAR) inside and outside the instructions for use (IFU) on outcomes in patients treated for ruptured abdominal aortic aneurysms (rAAA). Methods: All 112 patients (mean age 73 years; 102 men) treated with standard EVAR for rAAA between 2000 and 2012 in 3 European centers were included in the retrospective analysis. Patients were grouped based on aortic anatomy and whether EVAR was performed inside or outside the IFU. Data on complications, secondary interventions, and mortality were extracted from the patient records. Cox regression analysis was performed to assess predictors of mortality and complications; results are presented as the hazard ratio (HR) with 95% confidence interval (CI). Survival was analyzed using the Kaplan-Meier method. Results: Of the 112 patients examined, 61 (54%) were treated inside the IFU, 43 (38%) outside the IFU, and 8 patients lacked adequate preoperative computed tomography scans for determination. Median follow-up of those surviving 30 days was 2.5 years. Mortality at 30 days was 15% (95% CI 6% to 24%) inside the IFU vs 30% (95% CI 16% to 45%) outside (p=0.087). Three-year mortality estimates were 33.8% (95% CI 20.0% to 47.5%) inside the IFU vs 56% (95% CI 39.7% to 72.2%) outside (p=0.016). At 5 years, mortality was 48% (95% CI 30% to 66%) inside the IFU vs 74% (95% CI 54% to 93%) outside (p=0.015). Graft-related complications occurred in 6% (95% CI 0% to 13%) inside the IFU and 30% (95% CI 14% to 42%) outside (p=0.015). The rate of graft-related secondary interventions was 14% (95% CI 4% to 22%) inside the IFU vs 35% (95% CI 14% to 42%) outside (p=0.072). In the multivariate analysis, neck length <15 mm (HR 8.1, 95% CI 3.0 to 21.9, p<0.001) and angulation >60° (HR 3.1, 95% CI 1.0 to 9.3, p=0.045) were independent predictors of late graft-related complications. Aneurysm neck diameter >29 mm (HR 2.5, 95% CI 1.1 to 5.9, p=0.035) was an independent predictor of overall mortality. Conclusion: Long-term mortality and complications after rEVAR are associated with aneurysm anatomy. The role of adjunct endovascular techniques and the outcome of open repair in cases with challenging anatomy warrant further study.
Introduction
Endovascular aneurysm repair (EVAR) is increasingly used in the management of abdominal aortic aneurysm (AAA) as a less invasive alternative to open surgical repair. 1, 2 The increasing experience with EVAR and a new generation of devices has made the endovascular option applicable in emergency situations as well. Aneurysm neck anatomy is the most decisive factor in determining patient eligibility for EVAR. [3] [4] [5] [6] In ruptured AAAs (rAAAs), the anatomy is more often complex compared to elective cases. 7, 8 Despite this, EVAR for rAAA (rEVAR) is often advocated due to the minimally invasive nature of the procedure and its potential short-term benefits in survival and postoperative mobilization, [9] [10] [11] even though randomized trials comparing EVAR to open repair for rAAA have not shown any significant short-term survival benefit for the endovascular option. 12, 13 Mid-and long-term outcome of rEVAR, however, has been scarcely studied. In the IMPROVE trial, short aneurysm neck was associated with high 30-day mortality in patients treated with open repair. 14 Surprisingly, aneurysm anatomy did not affect 30-day mortality for rEVAR, possibly due to case selection. The objective of the present study was to assess the short-and long-term outcome after rEVAR depending on aneurysm anatomy in a real-world experience.
Methods

Study Design
This study involved 3 institutions with experience in EVAR, annually performing >50 aortic procedures each. Two institutions were university hospitals (Uppsala University Hospital, Uppsala, Sweden and Erasmus University Medical Center, Rotterdam, the Netherlands), and the third was a county hospital (Gävle Hospital, Gävle, Sweden). The study, which complied with the Declaration of Helsinki and local procedures for ethical clearance at each participating center, was planned and performed in accordance with the STROBE guidelines for observational cohort studies. 15 
EVAR and Follow-up Protocols
The study covers a long period from 2000 to 2012, and the selection of operation method changed over time in all 3 centers toward a primary EVAR strategy for ruptures in the latter period. Operators at the 3 centers used primarily Endurant (Medtronic Cardiovascular, Santa Rosa, CA, USA), Excluder (W.L. Gore & Associates, Flagstaff, AZ, USA), Zenith (Cook Medical Inc, Bloomington, IN, USA), and Talent (Medtronic Cardiovascular) stent-grafts. All EVAR patients were followed regularly using either computed tomography (CT) or ultrasound. In Uppsala, the follow-up was by duplex ultrasound at 1 month postoperatively, CT at 6 months, ultrasound at 12 months, and then biannual CT and ultrasound. In Rotterdam and Gävle, the follow-up program was CT at 1, 6, and 12 months and then yearly. Ultrasound replaced CT examinations in many cases in the last years of the study in all 3 centers.
Patient Selection and Data Management
The databases of the 3 centers were interrogated to identify all patients treated with rEVAR from January 2000 to December 2012. The same databases were used in a previously reported multicenter collaborative study on sac shrinkage after EVAR. 16 For this study, only patients with ruptured infrarenal aortic or aortoiliac aneurysm indicated on preoperative CT by contrast extravasation or retroperitoneal hematoma and treated with standard EVAR (no chimneys/ fenestrations) were eligible. Patients with symptomatic aneurysms without rupture, isolated iliac aneurysms, or patients with previous abdominal aortic surgery were excluded. Data from each institutional database were anonymized and entered into a study-specific database, recording baseline clinical and anatomic characteristics and procedural details (date, intraoperative details, endograft model, and configuration). Follow-up information included all registered complications, secondary interventions, and mortality.
Imaging Assessment
All imaging data were scrutinized by a single experienced vascular surgeon blinded for the outcome (H.B. in Sweden and F.B.G. in the Netherlands). Anatomic measurements were performed with 3-dimensional and central lumen of flow reconstructions using dedicated software (3mensio Medical Imaging B.V., Bilthoven, the Netherlands). After scrutiny of the preoperative CT, patients were dichotomized based on the measured aortic anatomy and its compliance with the device manufacturers' instructions for use (IFU) for the specific device implanted in each case, creating groups of patients treated inside vs outside the IFU. Table 1 lists the anatomic criteria from the IFUs of the stent-grafts commonly used in this study.
Definitions
Graft-related complications were defined as stent-graft migration >5 mm, graft limb thrombosis, conversion to open repair or aortouni-iliac (AUI) reconstruction, aneurysm rupture, endoleak types I or III, undefined endoleak, and sac expansion without clear endoleak. Intervention for graft-related complications referred to any intervention to manage the aforementioned complications. 
Patient Sample
In the observation period, of 383 patients treated for rAAA in the 3 participating institutions, 112 (29.3%) patients (mean age 73 years; 102 men) underwent rEVAR. Sixty-one (54.5%) of the rEVAR-treated patients fulfilled criteria for treatment inside the IFU and 43 (38.4%) patients were classified as outside the IFU. Eight (7.1%) patients lacked preoperative CT of adequate quality for anatomic assessment. Baseline demographics, clinical and anatomical characteristics, and endografts implanted are presented in Table 2 . The majority of patients (86, 77%) had one or more preoperative comorbidities.
Endpoints
The primary endpoint of this study was any graft-related complication, comparing patients treated inside the IFU with those treated outside the IFU. Secondary endpoints were secondary intervention for any graft-related complication, short and midterm mortality, direct or undetermined endoleaks, and endograft occlusion.
Statistical Analysis
A post hoc power analysis was performed to assess the power of the current study related to the primary endpoint of any graft-related complication. 17 Data were assessed for normality with histograms. Continuous variables are presented as the means or medians, while counts and percentages are given for categorical variables. Comparisons between the groups were performed using contingency table analysis with chi-square tests for categorical variables and t tests or Mann-Whitney U tests for continuous variables. The effect of potential predictors on overall 
Results
Group Comparison
Patients treated outside the IFU had larger aneurysms and a higher frequency of peripheral artery diseases than those treated within the IFU ( 
Intraoperative Complications and Adjunct Procedures
There was a significant difference between groups in the presence of intraoperative type I endoleak: 
Short-term Outcomes
Perioperative outcomes are presented in Table 3 . Nine patients died on the day of the operation [3 (4.9%) inside the IFU vs 6 (14.0%) outside (p=0.157)]. Mortality at 30 days was 15% (95% CI 6% to 24%) inside the IFU vs 30% (95% CI 16% to 45%) outside (p=0.087). The early trend toward higher mortality at 30 days in patients treated outside the IFU increased further at 90 days [37.2% outside the IFU (95% CI 22% to 52%) vs 14.8% inside the IFU (95% CI 6% to 24%), p=0.011]. There were no significant differences in the 30-day parameters for either postoperative complications or reinterventions.
Mid-and Long-term Outcomes
Median follow-up for patients surviving the first 30 days was 2.5 years (range 0-11.5). Two patients were lost to follow-up. Over this period ( Graft-related secondary intervention rates at 3 years ( Figure 2 ) were 16.7% (95% CI 3.7% to 29.6%) inside the IFU vs 42.3% (95% CI 20.7% to 63.8%) outside (p=0.060). At 5 years, the estimates were 16.7% (95% CI 3.7% to 29.6%) vs 76.0% (95% CI 50.8% to 100%), respectively (p=0.005). Overall mortality was higher in the outside the IFU group. Three-year mortality estimates ( Figure 3) were 33.8% (95% CI 20.0% to 47.5%) inside the IFU vs 56% (95% CI 39.7% to 72.2%) outside (p=0.016); 5-year mortality estimates were 47.8% (95% CI 29.9% to 65.6%) vs 73.6% (95% CI 54% to 93.2%), respectively (p=0.015).
One (1.6%) patient inside the IFU group died because of postimplantation rupture at 2 years after initial surgery. There were no perioperative deaths after aortic reintervention during follow-up. There were 7 type II endoleaks in the inside the IFU group and 1 in the outside the IFU group.
Multivariate and Power Analyses
Predictors of mortality and graft-related complications are presented in Table 5 . Age (HR 1.1, 95% CI 1.0 to 1.1, p=0.002) and neck diameter (HR 2.5, 95% CI 1.1 to 5.9, p=0.035) were predictors of overall mortality, while surgery under local anesthesia (HR 0.4, 95% CI 0.2 to 0.9, p=0.02) decreased the risk. Neck length <15 mm (HR 8.1, 95% CI 3.0 to 21.9, p<0.001) and angulation >60° (HR 3.1, 95% CI 1.0 to 9.3, p=0.045) were independent predictors of late graft-related complications. Eighty percent of the patients in the study were treated with the Endurant or Excluder devices. Outcome analysis comparing patients treated with these 2 stent-grafts did not reveal any significant differences in perioperative mortality, overall mortality, graft-related complications, or reinterventions.
The post hoc power analysis showed that the sample size and rates of graft-related complications in the 2 groups had an 83% power of detecting a significant difference at a 2-sided 0.05 significance level.
Discussion
The use of EVAR in the treatment of ruptures has increased rapidly over the past years. 18, 19 Endovascular repair for rAAA has had superior short-term survival when compared to open repair in most multicenter and single-center studies [20] [21] [22] ; although no early survival benefit was found in randomized controlled trials. 11, 13 Nonetheless, rEVAR allows earlier discharge to home and may be superior to open repair due to improved quality of life and lower treatment cost for rAAA. 12 Data on mid-and long-term outcome after rEVAR are scarce, however. The current analysis assessing 5-year results of rEVAR based on aneurysm anatomy indicates that expansion of standard rEVAR to those with challenging aortic anatomy (outside the IFU) is associated with significantly worse outcomes, both in terms of mortality and complications. The study is based on an international multicenter collaboration with meticulous patient follow-up for a disease with high postoperative mortality in order to achieve a relatively large number of cases and allow valid outcome analysis.
The short-and long-term risks of standard EVAR treatment of aneurysms with challenging aortic anatomy have been studied in the elective setting. 4, [23] [24] [25] [26] Standard EVAR has, however, been used in challenging aneurysm anatomy in elective cases with good results. 27 Proponents of rEVAR suggest that endovascular repair could be applied to most rupture cases. 9 Ruptured AAAs are in general larger than those treated electively and are more likely to have characteristics that prohibit rEVAR within the current devices' IFU. In the IMPROVE trial, 64% of the patients randomized to rEVAR were found eligible for endovascular repair based on anatomical criteria. 11 This number was even lower (39%) in the Amsterdam Acute Aneurysm Trial. 13 Overall, the 21% 30-day mortality rate in the current cohort was comparable to that of the rEVAR arm of the AJAX trial (22%) 13 and the rEVAR patients in the IMPROVE trial (27%), 14 despite the fact that ~40% of our patients were treated outside the IFU. In the current study, patients treated with rEVAR outside the IFU had higher rates of mid-and long-term mortality, graft-related complications, and secondary intervention compared to those treated inside the IFU. Aneurysm neck anatomy was a significant predictor of both mortality and graft-related complications in a multivariate analysis. Challenging aortic anatomy is not only a risk factor for endovascular repair; neck anatomy also affects outcome after open repair. In the IMPROVE trial, perioperative mortality for patients treated with open repair for rupture was clearly related to aneurysm neck length. 14 Thirty-day mortality was not significantly related to neck morphology in EVAR patients in the IMPROVE trial or in the current report. However, the current analysis indicates that mortality and complications beyond 30 days are affected by aortic morphology. Based on the shape of the Kaplan-Meier plot, most of the excess mortality in the outside the IFU group occurs during the first postoperative year. Patients treated outside the IFU had a 2-fold greater hazard ratio for overall mortality compared with those inside the IFU in a univariate analysis. Neck diameter >29 mm was the strongest predictor for overall mortality, while neck length <15 mm was associated with a 8-fold increase in the risk of graft-related complications.
The preferred treatment modality (open or endovascular repair) in cases with challenging anatomy cannot be settled based on these data alone, but they add to other existing data. In the IMPROVE trial, the open repair perioperative mortality was 50% for patients with aneurysm neck length <15 mm. 14 With increasing availability of complex endovascular techniques, it is possible that complex rEVAR will find a role in the treatment of patients with challenging aortic neck anatomy. In a recent study on rEVAR from Sweden, 1 or 2 renal chimney grafts increased EVAR suitability from 34% to 58%. 28 The increased secondary intervention and graft-related complication rates after rEVAR in these cases indicate a need for a specific follow-up program after rEVAR. Endovascular rupture repair outside the IFU can be regarded as a damage control strategy, followed by a more intensive surveillance program to detect and treat complications in timely fashion. The secondary intervention rate after rEVAR in the current cohort was higher than incidences reported for similar cohorts treated electively. 29, 30 The late graftrelated complications that occurred in one-fourth of the patients treated outside the IFU may question the benefit of rEVAR in these patients.
Limitations
The main limitation of the study is that it was retrospective. Selection of the repair method and device type in EVAR was based on the operators' experience and preference. The study focuses on patients treated with EVAR and does not allow comparison of mortality or secondary interventions to patients treated with open repair during the same period. The study assessed results in 3 centers over a 12-year period, during which progress in technical development and clinical practice occurred, potentially affecting outcome. However, a comparative analysis of two periods (2000-2005 and 2006-2012) did not demonstrate any significant difference in 30-day mortality in this cohort.
No interobserver variability assessment was performed for the anatomical measurements. However, these were performed by senior surgeons, and the validity of the measurement technique has previously been assessed. 31 Although the study analyzed long-term outcome in a relatively large cohort treated with rEVAR, the 5-year results presented are affected by low numbers due to the high mortality in this cohort of elderly patients. These data are therefore complemented by midterm analysis of 3-year outcome and Kaplan-Meier analyses.
Another limitation of the study was the difficulty in assessing the exact cause of death for all patients who died during the study period. As the study did not include patients treated with chimneys or fenestrated grafts for short-neck aneurysms, it was not possible to assess if introduction of these techniques would improve the outcome of rEVAR in the treatment of patients with rAAA who have an aortic anatomy outside the IFU.
Conclusion
Long-term mortality and complications after EVAR for rAAA are associated with aneurysm anatomy. Patients treated outside the IFU have higher mortality and rates of secondary intervention and graft-related complications. The role of endovascular techniques in the treatment of patients with complex aortic anatomy and infrarenal AAA rupture needs to be further studied to assess the role of adjunct endovascular techniques and to compare results to open repair in anatomically challenging cases. Surveillance programs should be adjusted for early detection of complications if rEVAR is performed on patients with aortic anatomy outside the IFU.
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